Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial
-
Published:2023-06
Issue:2
Volume:1
Page:119-124
-
ISSN:2772-5588
-
Container-title:Chinese Medical Journal Pulmonary and Critical Care Medicine
-
language:en
-
Short-container-title:Chinese Medical Journal Pulmonary and Critical Care Medicine
Author:
Han Rui,
Li Jianghua,
Wang Yubo,
He Tingting,
Zheng Jie,
He YongORCID